Vonoprazan ( DrugBank: Vonoprazan )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
63	特発性血小板減少性紫斑病	2
98	好酸球性消化管疾患	1

63. 特発性血小板減少性紫斑病

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03219723 (ClinicalTrials.gov)	September 1, 2015	9/7/2017	Drug Use Surveillance of Takecab for Supplement to Helicobacter Pylori Eradication	Drug Use Surveillance of Takecab Tablets Supplement to Helicobacter Pylori Eradication	Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gas ...	Drug: Vonoprazan;Drug: Amoxicillin hydrate;Drug: Clarithromycin;Drug: Metronidazole	Takeda	NULL	Completed	N/A	N/A	All	560		Japan
2	JPRN-JapicCTI-153003	01/9/2015		Drug use surveillance of Takecab for Supplement to Helicobacter pylori eradication	Drug use surveillance of Takecab tablets Supplement to Helicobacter pylori eradication	The following diseases in patients for whom H. pylori will be eradicated with triple therapy: Gastri ...	Intervention name : Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab ...	TAKEDA PHARMACEUTICAL COMPANY LTD.	NULL				BOTH	500	NA	NULL

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000021041	2016/02/15	15/02/2016	A study investigating the therapeutic effect of vonoprazanon the patients with proton pump inhibitor ...	A study investigating the therapeutic effect of vonoprazanon the patients with proton pump inhibitor ...	Eosinophilic esophagitis	administration of Vonoprazan (20mg/day for 2 months)	Second department of Internal Medicine, Shimane University Faculty of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	5	Not selected	Japan